AstraZeneca's COVID-19 vaccine wins Australian nod

  • Australia’s regulator approves AstraZeneca's (NASDAQ:AZN) vaccine as its second for use against COVID-19.
  • Pfizer 's (NYSE:PFE) product will be available in Australia next week which will be given in two doses three weeks apart, while AstraZeneca's dose will be administered in two doses 12 weeks apart.
  • The Therapeutic Goods Administration found the AZN vaccine was safe and effective. Health Minister Greg Hunt said the AstraZeneca vaccine will prevent serious COVID-19 illness.
  • Prime Minister Scott Morrison will be vaccinated with the PFE shot and Hunt with AZN in a demonstration of confidence in both vaccines.
  • Australia has contracted 53.8M doses of the AstraZeneca vaccine, and 50M of those will be manufactured in Australia.
  • The government has also secured 20M doses of Pfizer vaccines for a population of 26M.

    Astrazeneca fundamentals

    Investors in Astrazeneca can expect a huge dividend payment. Based on the recent analysts' consensus the stock now has one of the highest dividend returns of the English market. Per share the analysts expect a dividend of 284 GBp per share. Thus the dividend yield equals 3.81 percent. The average dividend yield of the pharmaceutical companies equals a poor 0.38 percent.

    Historical dividend returns Astrazeneca

    Over the current book year the company from Cambridge could achieve a revenue around 30.94 billion GBp (consensus estimates). This is hugely more than 2019's revenue of 26.62 billion GBp.

    Historical revenues and results Astrazeneca plus estimates 2020

    fundamantele data Astrazeneca

    The analysts expect for 2020 a net profit of 6.83 billion GBp. For this year the consensus of Astrazeneca 's result per share is a profit of 505 GBp. The price/earnings-ratio is then 14.76.

    Latest estimates around 8044 GBp

    The latest 3 recommendations for the pharmaceutical company were provided by HSBC , KBC Securities and UBS .

    Astrazeneca 's market capitalization is based on the number of outstanding shares around 9780.68 billion GBp. The Astrazeneca stock was the past 12 months quite volatile. Since last February the stock is 1 percent higher. This year the stock price moved between 5871 and 10120 GBp.

    Price data Astrazeneca 2007-2020

    stock prices astrazeneca

    Click here for dividend Astrazeneca. At 13.25 the stock trades 2.11 percent lower at 7454 GBp. Nieuwsdienst: +31 084-0032-842

    Copyright B.V.
    All rights reserved. Any redistribution, duplication or archiving prohibited. doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.